RECEPTA BIOPHARMA

Recepta Biopharma engages in the research, development, production, and commercialization of biopharmaceuticals. It offers a range of biomolecules such as humanized monoclonal antibodies and peptides that are used in the diagnosis and treatment of various types of cancers as well as used as biomarkers for diagnostic purposes and disease progression and/or response to treatment prognosis. Recepta Biopharma began operation in 2006, with its headquarters in São Paulo in Brazil. It operates as a subsidiary of Financiadora de Estudos e Projetos.